PT  - JOURNAL ARTICLE
AU  - Summers, Jaye
ED  - Freedman, Mark
TI  - REFLEXION Trial
DP  - 2015 Jun 20
TA  - MD Conference Express
PG  - 14--15
VI  - 15
IP  - 9
4099  - http://mdc.sagepub.com/content/15/9/14.2.short
4100  - http://mdc.sagepub.com/content/15/9/14.2.full
AB  - Many who experience a first demyelinating clinical event will convert to clinically definite multiple sclerosis. Data from the REFLEX and REFLEXION trials suggest that patients who receive early treatment with interferon beta 1-a will convert to multiple sclerosis later than patients who took placebo prior to receiving interferon beta 1-a.